See more : Republic Healthcare Limited (8357.HK) Income Statement Analysis – Financial Results
Complete financial analysis of Chison Medical Technologies Co., Ltd. (688358.SS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Chison Medical Technologies Co., Ltd., a leading company in the Medical – Specialties industry within the Healthcare sector.
- Re:NewCell AB (publ) (RENEW.ST) Income Statement Analysis – Financial Results
- Ventia Services Group Limited (VNT.NZ) Income Statement Analysis – Financial Results
- Helport AI Limited Warrants (HPAIW) Income Statement Analysis – Financial Results
- ShunSin Technology Holdings Limited (6451.TW) Income Statement Analysis – Financial Results
- Union Optech Co.,Ltd. (300691.SZ) Income Statement Analysis – Financial Results
Chison Medical Technologies Co., Ltd. (688358.SS)
Industry: Medical - Specialties
Sector: Healthcare
About Chison Medical Technologies Co., Ltd.
Chison Medical Technologies Co Ltd is a manufacturer and seller of ultrasound medical imaging equipment. The company provides ultrasound diagnostic equipment, health equipment, instrumentation, electronic components, electronic products, electronic equipment, trolleys, general equipment and accessories. Its products include Color Doppler, and B/W system.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
---|---|---|---|---|---|---|---|---|
Revenue | 483.84M | 380.84M | 397.81M | 333.09M | 369.76M | 326.97M | 271.62M | 166.95M |
Cost of Revenue | 199.31M | 155.06M | 173.88M | 137.97M | 144.52M | 127.04M | 110.23M | 70.96M |
Gross Profit | 284.53M | 225.78M | 223.93M | 195.12M | 225.24M | 199.92M | 161.39M | 95.99M |
Gross Profit Ratio | 58.81% | 59.28% | 56.29% | 58.58% | 60.91% | 61.14% | 59.42% | 57.49% |
Research & Development | 77.07M | 77.88M | 72.29M | 55.64M | 52.02M | 41.35M | 33.12M | 28.27M |
General & Administrative | 10.55M | 13.42M | 10.92M | 7.04M | 7.93M | 8.33M | 23.29M | 11.96M |
Selling & Marketing | 52.82M | 50.29M | 49.82M | 38.40M | 50.39M | 45.49M | 36.35M | 29.10M |
SG&A | 63.37M | 63.71M | 60.74M | 45.44M | 58.32M | 53.83M | 59.64M | 41.06M |
Other Expenses | -18.14M | 6.36M | 4.25M | 3.52M | 1.57M | -2.66M | 2.49M | 7.10M |
Operating Expenses | 113.28M | 147.95M | 137.27M | 104.59M | 111.91M | 93.79M | 83.59M | 71.18M |
Cost & Expenses | 321.62M | 303.01M | 311.15M | 242.56M | 256.43M | 220.83M | 193.83M | 142.15M |
Interest Income | 29.60M | 0.00 | 0.00 | 0.00 | 0.00 | 338.79K | 112.09K | 0.00 |
Interest Expense | 11.36M | 0.00 | 0.00 | 0.00 | 0.00 | 17.56K | 0.00 | 0.00 |
Depreciation & Amortization | 14.26M | 13.16M | 10.12M | 8.43M | 6.89M | 6.15M | 4.93M | 4.71M |
EBITDA | 177.24M | 125.83M | 132.01M | 120.22M | 125.26M | 113.58M | 79.31M | 38.57M |
EBITDA Ratio | 36.63% | 33.70% | 26.85% | 35.80% | 34.39% | 35.09% | 30.72% | 18.70% |
Operating Income | 162.22M | 115.13M | 96.93M | 108.78M | 115.98M | 106.71M | 71.53M | 26.41M |
Operating Income Ratio | 33.53% | 30.23% | 24.37% | 32.66% | 31.37% | 32.64% | 26.33% | 15.82% |
Total Other Income/Expenses | -28.94K | -1.32K | -486.39K | 2.73M | 1.97M | 367.30K | 2.49M | 7.10M |
Income Before Tax | 162.19M | 115.13M | 124.54M | 111.51M | 117.95M | 107.08M | 74.01M | 33.51M |
Income Before Tax Ratio | 33.52% | 30.23% | 31.31% | 33.48% | 31.90% | 32.75% | 27.25% | 20.07% |
Income Tax Expense | 15.71M | 9.29M | 12.07M | 11.88M | 12.81M | 12.01M | 9.97M | 3.05M |
Net Income | 146.48M | 105.84M | 112.47M | 99.64M | 105.13M | 95.06M | 64.04M | 30.47M |
Net Income Ratio | 30.27% | 27.79% | 28.27% | 29.91% | 28.43% | 29.07% | 23.58% | 18.25% |
EPS | 1.33 | 0.94 | 1.00 | 0.89 | 0.94 | 1.13 | 0.76 | 0.36 |
EPS Diluted | 1.33 | 0.94 | 1.00 | 0.89 | 0.94 | 1.13 | 0.76 | 0.36 |
Weighted Avg Shares Out | 110.14M | 112.12M | 112.00M | 112.00M | 112.00M | 84.23M | 83.79M | 83.63M |
Weighted Avg Shares Out (Dil) | 110.14M | 112.12M | 112.00M | 112.00M | 112.00M | 84.23M | 83.79M | 83.63M |
Source: https://incomestatements.info
Category: Stock Reports